Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis

Sponsor
Albert Einstein Healthcare Network (Other)
Overall Status
Terminated
CT.gov ID
NCT01599195
Collaborator
(none)
18
1
81.1
0.2

Study Details

Study Description

Brief Summary

The purpose of the study is to test a new amplified stethoscope(AudioDoc) that can detect the presence of bruit by using an acoustic signal to represent the bruit. This pilot study will address two questions: is there a detectable difference in recorded sound signal of carotid and femoral bruit when compared to sound signals captured when there is no bruit present; is the use of a visual recorded signal more accurate in identifying carotid and femoral bruit when compared to traditional auscultation with a regular stethoscope and ultrasound.

Condition or Disease Intervention/Treatment Phase
  • Device: AudioDoc

Detailed Description

Recorded signals are stored on a laptop computer. The signals later undergo Fourier analysis are then compared to the findings on carotid ultrasoud as to degree of stenosis. Subjects with high grade stenosis in which no bruit was ascultated but in which carotid ultrasound data suggests a bruit may be present are studied for soft /inaudible bruits. When available, data will be correlated to CT/conventional angiographic studies.

Study Design

Study Type:
Observational
Actual Enrollment :
18 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Actual Study Start Date :
Apr 1, 2010
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Jan 1, 2017

Arms and Interventions

Arm Intervention/Treatment
adults

adults audiodoc use to evaluate for carotid or femoral bruit

Device: AudioDoc
AudioDoc will be used to identify the carotid and femoral bruit

Outcome Measures

Primary Outcome Measures

  1. Comparison of bruit signal obtained from the amplified stethoscope(AudioDoc) to that found by conventional ultrasonography. [subjects will be followed for duration of hospital stay, typically four days.]

Secondary Outcome Measures

  1. To assess the frequency spectral differences obtained from the different recording modalities [duration of hospital stay, typically four days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age 19-90 years

  • having clinical ultrasound evaluation of carotid or femoral artery

Exclusion Criteria:
  • under age 19; over age 90 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Albert Einstein Healthcare Network Philadelphia Pennsylvania United States 19141

Sponsors and Collaborators

  • Albert Einstein Healthcare Network

Investigators

  • Principal Investigator: Jonathan Dissin, MD, Albert Einstein Healthcare Network

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jonathan Dissin, MD, Principal Investigator, Albert Einstein Healthcare Network
ClinicalTrials.gov Identifier:
NCT01599195
Other Study ID Numbers:
  • HN 4209
First Posted:
May 15, 2012
Last Update Posted:
Feb 1, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jonathan Dissin, MD, Principal Investigator, Albert Einstein Healthcare Network
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2017